EUVIMEDEUVIMED entdecken
Metaanalyse

Diagnostic accuracy of serum pepsinogens for detecting chronic atrophic gastritis and gastric cancer: A meta-analysis

Ganchimeg Dondov, Bayarmaa Nyamaa, Batbold Batsaikhan, Tegshjargal Badamjav, Sodnomtsogt Lkhagvasuren, Tulgaa Lonjid

Eurasian Journal of Medicine and Oncology · 07.07.2026 · 026110126

DOI: 10.36922/ejmo026110126 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Eurasian Journal of Medicine and Oncology, online erschienen am 07.07.2026. Verfasst von Ganchimeg Dondov und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Recent studies have shown that serological biomarkers such as pepsinogens may facilitate the early detection of gastric cancer.

Objective

This study aims to evaluate the diagnostic performance of serum pepsinogen I (PGI) and the PGI/pepsinogen II ratio (PGR) in detecting gastric cancer and chronic atrophic gastritis.

Methods

A systematic literature search was conducted using MeSH terms related to atrophic gastritis, gastric neoplasms, pepsinogen A, sensitivity, and specificity. Twenty-one eligible studies were included in the quantitative synthesis.

Results

For atrophic gastritis, the area under the curve was 0.74 (95% confidence interval [CI] = 0.70–0.77) for PGI and 0.78 (95% CI = 0.75–0.82) for PGR. The pooled sensitivity and specificity were 61.4% (95% CI = 48.2–73.2) and 86.4% (95% CI = 61.8–96.1), respectively, for PGI, and 72.4% (95% CI = 61.0–81.4) and 76.9% (95% CI = 49.5–91.9), respectively, for PGR. For gastric cancer detection, the area under the curve values were 0.76 (95% CI = 0.72–0.80) for PGI, 0.77 (95% CI = 0.73–0.80) for PGR, and 0.79 (95% CI = 0.75–0.83) for the combined PGI+PGR model. The pooled sensitivity and specificity were 69.8% (95% CI = 55.0–81.3) and 70.8% (95% CI = 58.7–80.6), respectively, for PGI, 76.2% (95% CI = 65.4–84.2) and 66.1% (95% CI = 56.1–74.8), respectively, for PGR, and 61.5% (95% CI = 50.9–72.1) and 86.7% (95% CI = 79.4–94.1), respectively, for PGI+PGR.

Conclusion

Serum PGI and PGR can be used as an additional screening for high-risk subjects who may require gastroscopy or biopsy.

Zitieren

APA

Dondov, G., Nyamaa, B., Batsaikhan, B., Badamjav, T., Lkhagvasuren, S., & Lonjid, T. (2026). Diagnostic accuracy of serum pepsinogens for detecting chronic atrophic gastritis and gastric cancer: A meta-analysis. Eurasian Journal of Medicine and Oncology, 0(0), 026110126. https://doi.org/10.36922/ejmo026110126

Vancouver

Dondov G, Nyamaa B, Batsaikhan B, Badamjav T, Lkhagvasuren S, Lonjid T. Diagnostic accuracy of serum pepsinogens for detecting chronic atrophic gastritis and gastric cancer: A meta-analysis. Eurasian Journal of Medicine and Oncology. 2026;0(0):026110126. doi:10.36922/ejmo026110126

BibTeX
@article{Dondov2026,
  author = {Dondov, Ganchimeg and Nyamaa, Bayarmaa and Batsaikhan, Batbold and Badamjav, Tegshjargal and Lkhagvasuren, Sodnomtsogt and Lonjid, Tulgaa},
  title = {Diagnostic accuracy of serum pepsinogens for detecting chronic atrophic gastritis and gastric cancer: A meta-analysis},
  journal = {Eurasian Journal of Medicine and Oncology},
  year = {2026},
  volume = {0},
  number = {0},
  pages = {026110126},
  doi = {10.36922/ejmo026110126}
}
Kostenlos starten →